PubMed Health⌕ Search

Biomedical subjects

A O Tolentino

Publications and source records attributed to A O Tolentino.

4 recordsLinked to original sources

New principles for optimum left ventriculography.

Left ventriculography has become the single most important procedure in the evaluation of cardiac function. This study reevaluated the refinements of catheter and power injector technology to assess recommendations of past years and establish new principles for optimum ventriculography. Ventriculograms from 102 patients undergoing left heart catheterization and coronary arteriography for coronary, valvular, and myocardial heart disease served as the test sample. Three styles of #7F high-flow 110-cm pigtail catheters were utilized. One had 12 sideholes while the other two had six sideholes positioned nearer the base of the curl. Analysis of ventriculographic quality of each angiogram was performed by three of the authors independently and subsequently together. Five variables were analyzed for their effect on the diagnostic quality of the angiogram: 6-hole catheters, 12-hole catheters, volume of contrast, flow rate, and location of injection. Once these analyses were complete, the effect of combinations of these variables was tested to determine their effect on angiographic quality. The first combination included contrast volume and flow rate. The second combination compared contrast volume and flow rate when utilized with 6- or 12-hole catheters. The third combination tested the 6- and 12-hole catheters in the apex or inflow locations. A multivariate contingency analysis was used to define relationships between the variables and the quality of the angiogram obtained. As independent variables, catheter style, volume of contrast, flow rate, and location of injection did not influence angiographic quality. However, the apex as a location of injection was the single most consistently important determinant of ventricular angiographic quality.(ABSTRACT TRUNCATED AT 250 WORDS)

Cardiac Catheterization↗

Pacer-induced tachycardia associated with an atrial synchronous ventricular inhibited (ASVIP) pulse generator.

A 68-year-old white male underwent permanent pacemaker implantation with an atrial synchronous ventricular inhibited pulse generator (Medtronic model 2409) because of syncope and abnormal H-V interval of 70 ms. Paroxysmal bouts of pacemaker associated tachycardia were subsequently recorded on several occasions, initiated and terminated by spontaneous ventricular premature beats. The mechanism for the occurrence of the tachyarrhythmia is discussed in detail and the functional characteristics of the pulse generator are described. Replacement of the unit with a different pacer device prevented further occurrence of the arrhythmia.

Aged↗

Echocardiographic observations on the association between mitral valve prolapse and asymmetric septal hypertrophy.

One hundred and ninety consecutive patients with mitral valve prolapse (MVP) were studied by echocardiography. Asymmetric septal hypertrophy (ASH) was noted in 16 patients. Three patients had syncope which was associated with supraventricular arrhythmias. Three others had episodes of presyncope which were not related to rhythm disturbances. One of the patients with MVP and ASH had a family history of idiopathic hypertrophic subaortic stenosis. The septal thickness ranged from 1.6 to 3.1 cm, mean = 2 cm. The posterior wall thickness ranged from 0.7 to 2.1 cm, mean = 1.0 cm. The ratio of the thickness of the interventricular septum to that of the posterior wall ranged from 1.5 to 2.5, mean = 1.9. The percentage of thickening of the septum in systole was reduced in 13 patients. The excursion of the interventricular septum was reduced in three patients. In nine patients the left ventricular end-systolic dimension was below the lower limit of normal. Percentage fractional shortening of the left ventricle was increased in eight patients. Since MVP predisposes to cardiac arrhythmias which are poorly toletated in the setting of ventricular hypertrophy and reduced left ventricular compliance, the recognition of this combination of MVP and ASH is of clinical importance.

Adolescent↗